FY2025 · period end Dec '25 · from the 10-K filed Feb 19, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $77.08B | $70.99B | $66.91B | $68.77B | $68.70B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $6.14B | $6.00B | $5.72B | $5.98B | — |
| Net Income | $3.38B | $4.43B | $1.58B | $5.28B | $6.86B |
| EPS (Diluted) | $4.71 | $5.94 | $1.81 | $6.30 | $7.65 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $745.17B | $677.46B | $687.58B | $663.07B | $759.71B |
| Total Liabilities | $716.25B | $649.75B | $657.33B | $632.95B | $691.96B |
| Stockholders' Equity | $28.68B | $27.70B | $30.25B | $30.13B | $50.01B |
| Cash & Equivalents | $22.03B | $20.07B | $20.64B | $20.20B | $20.05B |
| Total Debt | $14.47B | $15.09B | $15.55B | $14.65B | $13.93B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $17.09B | $14.60B | $13.72B | $13.04B | $12.35B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | — |
| Net Margin | 0.0% | 0.1% | 0.0% | 0.1% | 10.0% |
| Return on Equity | 12.0% | 15.3% | 5.2% | 13.2% | 13.7% |
| Return on Assets | 0.5% | 0.6% | 0.2% | 0.7% | 0.9% |
| Debt / Equity | 0.50× | 0.54× | 0.51× | 0.49× | 0.28× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001099219-26-000052 | Aug 17, 2026 | Aug 17, 2026 | Aug 17, 2026 20:30 UTC | EDGAR |
| 10-Q | 0001099219-26-000050 | Jun 30, 2026 | Aug 6, 2026 | Aug 6, 2026 20:32 UTC | EDGAR |
| 8-K | 0001099219-26-000048 | Aug 5, 2026 | Aug 5, 2026 | Aug 5, 2026 20:31 UTC | EDGAR |
| 8-K | 0001099219-26-000045 | Jun 29, 2026 | Jun 29, 2026 | Jun 29, 2026 10:27 UTC | EDGAR |
| 8-K | 0001099219-26-000041 | Jun 16, 2026 | Jun 22, 2026 | Jun 22, 2026 20:21 UTC | EDGAR |
| 8-K | 0001099219-26-000037 | May 15, 2026 | May 15, 2026 | May 15, 2026 20:18 UTC | EDGAR |
| 10-Q | 0001099219-26-000035 | Mar 31, 2026 | May 7, 2026 | May 7, 2026 21:09 UTC | EDGAR |
| 8-K | 0001099219-26-000032 | May 6, 2026 | May 6, 2026 | May 6, 2026 20:31 UTC | EDGAR |
Direct links to SEC EDGAR. MET has additional filings available on the SEC site.
6 numbers METLIFE INC later changed — same XBRL tag, both filings linked.
Net Income (Loss) Available to Common Stockholders, Basic·Q2 2022
Major restatementwas$103M
Revised up in a 10-K.
Net Income (Loss) Attributable to Parent·Q2 2022
Major restatementwas$132M
Revised up in a 10-K. Any P/E built on the original was 85.5% too high.
Net Income (Loss) Available to Common Stockholders, Basic·Q2 2016
Major restatementwas$64M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q3 2022
Major restatementwas$419M
Revised up in a 10-Q.
Net Income (Loss) Available to Common Stockholders, Basic·Q3 2022
Major restatementwas$331M
Revised up in a 10-K.
Net Income (Loss) Attributable to Parent·Q3 2022
Major restatementwas$395M
Revised up in a 10-K. Any P/E built on the original was 66.0% too high.
MET is not the only one.
See every restatement we've found across the market — or get an alert the next time MET revises a number.
Restatements are detected by comparing every vintage of a fact across all of METLIFE INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows MET's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling METLIFE INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on MET yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on MET and publish the result to your public profile.
Ask about METLIFE INC
Continue in Workspace — cited answers on MET, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs